Drug Profile


Alternative Names: DRF-3188; DRF-ACXX

Latest Information Update: 08 Feb 2008

Price : $50

At a glance

  • Originator Dr Reddys Research Foundation
  • Class Antineoplastics; Antivirals
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Cancer; Viral infections

Most Recent Events

  • 31 Jan 2003 Suspended - Preclinical for Viral infections in India (unspecified route)
  • 31 Jan 2003 Suspended - Preclinical for Cancer in India (unspecified route)
  • 23 Nov 2000 Preclinical development for Viral infections in India (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top